Mefloquine hydrochloride
-
Mefloquine hydrochloride
structure -
-
CAS No:
51773-92-3
-
Formula:
C17H16F6N2O.ClH
-
Chemical Name:
Mefloquine hydrochloride
-
Synonyms:
4-Quinolinemethanol,α-(2R)-2-piperidinyl-2,8-bis(trifluoromethyl)-,hydrochloride (1:1),(αS)-rel-;4-Quinolinemethanol,α-2-piperidinyl-2,8-bis(trifluoromethyl)-,monohydrochloride,(R*,S*)-(±)-;4-Quinolinemethanol,α-(2R)-2-piperidinyl-2,8-bis(trifluoromethyl)-,monohydrochloride,(αS)-rel-;Mefloquine hydrochloride;WR 142490;4-Quinolinemethanol,α-2-piperidinyl-2,8-bis(trifluoromethyl)-,monohydrochloride,(R*,S*)-;Loriam;Ro 21-5998/001;NSC 157387;Mefloquin hydrochloride;(±)-Mefloquine hydrochloride;68682-28-0
- Categories:
-
CAS No:
Description
Mefloquine hydrochloride is a quinoline antimalarial drug that is structurally related to the antiarrhythmic agent quinidine. IC50 Value: 1 microM ( for K+ channel) [1]Target: AntiparasiticMefloquine is widely used in both the treatment and prophylaxis of Plasmodium falciparum malaria. MQ can induces oxidative stress in vitro. Evidence indicates that reactive oxygen species (ROS) may be used as a therapeutic modality to kill cancer cells [2].in vitro: Mefloquine inhibitedKvLQT1/minK chan
Mefloquine hydrochloride is a hydrochloride.|Mefloquine is a quinoline derivative used for the prevention and therapy of P. falciparum malaria. Mefloquine therapy is associated with a low rate of transient and asymptomatic serum enzyme elevations and is a rare cause of clinically apparent acute liver injury.|A phospholipid-interacting antimalarial drug (ANTIMALARIALS). It is very effective against PLASMODIUM FALCIPARUM with very few side effects.
Mefloquine hydrochloride Basic Attributes
414.77
378.116669
257-412-0
326VC85GV6
DTXSID1047819
2933399090
Characteristics
45.2 Ų
white solid
1.4±0.1 g/cm3
259-260 °C (decomp)
205.2±27.3 °C
1.519
DMSO: 38 mg/mL, soluble
Refrigerator
Safety Information
UN 3077 9 / PGIII
3
22
VC0308000
Xn
P301 + P312 + P330
H302
|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P301+P312, P330, and P501|Aggregated GHS information provided by 94 companies from 4 notifications to the ECHA C&L Inventory.
Toxicity
Chronic therapy with mefloquine is associated with asymptomatic, transient serum enzyme elevations in up to 18% of patients. These elevations are usually mild and resolve without dose modifications. Despite widespread use, mefloquine has rarely been linked to clinically apparent acute liver injury and too few reports are available to characterize the clinical features of such injury. Instances of acute hepatocellular injury as well as cholestatic hepatitis have been linked to use of mefloquine. Allergic manifestations (rash, fever, eosinophilia) and autoantibody formation are rare.
Drug Information
Mefloquine is a quinoline derivative used for the prevention and therapy of P. falciparum malaria. Mefloquine therapy is associated with a low rate of transient and asymptomatic serum enzyme elevations and is a rare cause of clinically apparent acute liver injury.
Antimalarial Agents
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)
Lariam
Mefloquine hydrochloride Use and Manufacturing
Solutions of (+/-)-erythro-mefloquinium chloride (2 mmol) and sodium tetraethylborate (2 mmol) in ethanol were mixed and stirred overnight. The reaction mixture was filtered to remove sodium chloride and the mother liquor was left at room temperature. After a period, crystals of (+/-)-erythro-mefloquine were collected. IR and NMR spectral data were in agreement with published data.Solution of mefloquinium chloride (2 mmol) and sodium tetraphenylborate (2 mmol) in acetone were mixed and stirred overnight. The reaction mixture was filtered to remove sodium chloride and the mother liquor was left at room temperature. After a period, crystals of (+/-)-erythro-mefloquinium tetraphenylborate monoacetone solvate, (3*Me2CO), were collected, m.p 137-139 C (with evolution of gases).
Quinoline methanol antimalarial agent.
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:414.8
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:9
Rotatable Bond Count:2
Exact Mass:414.0933598
Monoisotopic Mass:414.0933598
Topological Polar Surface Area:45.2
Heavy Atom Count:27
Complexity:483
Defined Atom Stereocenter Count:2
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Recommended Suppliers of Mefloquine hydrochloride
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
CN
5 YRS
Business licensedTrader Supplier of PVC resin,pvc paste resin,melamineInquiryCAS No.: 51773-92-3Grade: Industrial GradeContent: 99%
Latest News on Mefloquine hydrochloride
- The world's first uniform international safety standard for plastics and rubber
- The nation's first group standard for meltblown cloth for masks is released
- Several compulsory national standards have been issued
- Japan has seized the right to formulate international standards
- Henan Efforts to Improve the Standardized Management Level of Food Production
Learn More Other Chemicals
-
4H-1-Benzopyran-4-one, 2-[4-[3-(dibutylamino)propoxy]-3,5-dimethylbenzoyl]-, hydrochloride (1:1)
67652-33-9
-
Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, ethyl ester, hydrochloride (9CI)
681807-60-3
-
CYCLOPENTYL-(3,4,5-TRIMETHOXY-BENZYL)-AMINE HYDROCHLORIDE
1052525-88-8
-
2-Cyclopropylbenzenemethanamine hydrochloride Formula
118184-64-8
-
Des[4-(2-cycloproylMethoxy)] Betaxolol Hydrochloride Formula
464877-45-0
-
Ethanamine, 2-(decylthio)-, hydrochloride (1:1) Formula
36362-09-1
-
4,7-Dichloro-2-propylquinoline hydrochloride Structure
1204812-22-5
-
6,7-Dichloro-4-hydrazino-2-methylquinoline hydrochloride Structure
1170377-12-4
-
What is 2,8-Diazaspiro[4.5]decan-1-one, 2-[(4-bromophenyl)methyl]-, hydrochloride (1:1)
832710-56-2
-
What is 6,7-Dichloro-4-hydrazinoquinoline hydrochloride
1171843-02-9